Medication info
Posilogen Es Tablets (Dapagliflozin Propanediol Monohydrate, Sitagliptin Phosphate Monohydrate)

Posilogen Es Tablets (Dapagliflozin Propanediol Monohydrate, Sitagliptin Phosphate Monohydrate)

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
한화제약(주)
Appearance
Beige oval film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202300056 · Approved 2023.01.05 · Insurance code 651602860

Summary

Main use
Improvement in blood glucose control for type 2 diabetes
Who uses it
Adults
Adult dosage
This medication may be administered at a dosage of 1 tablet once daily with or without food to patients receiving Sitagliptin 100 mg and Dapagliflozin 10 mg. The tablet should be swallowed whole.

Ingredients

Manufacturer
한화제약(주)

Efficacy & effects

Improvement in blood glucose control for type 2 diabetes

View approved original text

This medication is used in patients with type 2 diabetes to help achieve effective blood glucose control when taking Sitagliptin and Dapagliflozin together, along with diet and exercise therapy. In other words, it is a treatment designed to lower blood glucose levels and provide significant assistance in managing diabetes.

Dosage and Administration

Adult dosage

This medication may be administered at a dosage of 1 tablet once daily with or without food to patients receiving Sitagliptin 100 mg and Dapagliflozin 10 mg. The tablet should be swallowed whole.

Precautions

This medication may cause severe allergic reactions due to the Sitagliptin ingredient, so if symptoms such as skin rash, breathing difficulty, or swelling of the face or neck occur, discontinue use immediately and consult a healthcare professional. This medication may cause acute pancreatitis, a serious inflammation of the pancreas; therefore, if symptoms such as abdominal pain, nausea, or vomiting develop, inform a healthcare professional immediately. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. In patients with reduced fluid volume or impaired kidney function, this medication may cause low blood pressure or kidney damage, so kidney function and fluid status should be carefully monitored before and during administration. When used in conjunction with medications that have a risk of hypoglycemia, such as insulin or sulfonylureas, this medication may increase the risk of hypoglycemia, so dose adjustment of these medications may be necessary. This medication may increase the risk of genital infections and urinary tract infections, so appropriate treatment should be sought if related symptoms occur. Elderly patients may have a higher risk of reduced fluid volume and low blood pressure, so caution is advised in their use. Women who are pregnant or breastfeeding are advised not to use this medication, and if pregnancy is confirmed, use should be discontinued immediately. Safety and efficacy in pediatric patients under 18 years old have not been established, so use should be avoided in this population. In case of overdose, there is no specific antidote; appropriate management should be implemented based on symptoms, and blood dialysis may be considered if necessary. This medication does not significantly affect the ability to drive or operate machinery, but caution should be exercised as hypoglycemic symptoms may occur. The product should be stored out of reach of children and kept in its original container for safety.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by cough + fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

  • Hypoglycemia
  • dry mouth
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • polyuria
  • nocturia
  • itching of the vulva
  • itching of the genitals
Show 22 more
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased blood creatinine
  • increased blood urea
  • weight loss
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • headache
  • fever
  • foreign body sensation
  • pain
  • itching
  • urticaria
  • cold sweat
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Beige oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.